Biblio

2013
Xia J, Wang L. Pelizaeus-Merzbacher disease: Molecular diagnosis and therapy. Intractable Rare Dis Res. 2013;2(3):103-5.
Taft RA, Low BE, Byers SL, Murray SA, Kutny P, Wiles MV. The Perfect Host: A Mouse Host Embryo Facilitating More Efficient Germ Line Transmission of Genetically Modified Embryonic Stem Cells. PLoS One. 2013;8(7):e67826.
Xu B, Chen X, Mao Z, Chen M, Han X, Du G, Ji X, Chang C, Rehan VK, Wang X, et al. Perfluorooctane Sulfonate Disturbs Nanog Expression through miR-490-3p in Mouse Embryonic Stem Cells. PLoS One. 2013;8(10):e74968.
Muramatsu D, Singh PB, Kimura H, Tachibana M, Shinkai Y. Pericentric heterochromatin generated by HP1 interaction-defective histone methyltransferase Suv39h1. J Biol Chem. 2013.
Mendel TA, Clabough EBD, Kao DS, Demidova-Rice TN, Durham JT, Zotter BC, Seaman SA, Cronk SM, Rakoczy EP, Katz AJ, et al. Pericytes Derived from Adipose-Derived Stem Cells Protect against Retinal Vasculopathy. PLoS One. 2013;8(5):e65691.
Dalby MJ, C Y Lee L, Yang J, MacIntyre A, McCully M. Periodicity is important in stem cell response. Nanomedicine (Lond). 2013;8(11):1744.
Wang X, Liu J, Wang Z, Huang Y, Liu W, Zhu X, Cai Y, Fang X, Lin S, Yuan L, et al. Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells. PLoS One. 2013;8(8):e72962.
Skarbnik AP, Burki M, Pro B. Peripheral T-cell lymphomas: a review of current approaches and hopes for the future. Front Oncol. 2013;3:138.
Kim NRae, Lim S, Jeong J, Cho HYee. Peritoneal and nodal gliomatosis with endometriosis, accompanied with ovarian immature teratoma: a case study and literature review. Korean J Pathol. 2013;47(6):587-91.
Katare R, Riu F, Rowlinson J, Lewis A, Holden R, Meloni M, Reni C, Wallrapp C, Emanueli C, Madeddu P. Perivascular Delivery of Encapsulated Mesenchymal Stem Cells Improves Postischemic Angiogenesis Via Paracrine Activation of VEGF-A. Arterioscler Thromb Vasc Biol. 2013.
Puig I, Chicote I, Tenbaum SPaul, Arques O, Herance JRaul, Gispert JD, Jimenez J, Landolfi S, Caci K, Allende H, et al. A Personalized Pre-clinical Model to Evaluate the Metastatic Potential of Patient-derived Colon Cancer Initiating Cells. Clin Cancer Res. 2013.
Triscott J, Lee C, Foster C, Manoranjan B, Pambid MRose, Berns R, Fotovati A, Venugopal C, O'Halloran K, Narendran A, et al. Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase PLK1 as a molecular target in high-risk children. Cancer Res. 2013.
Aimone JB, Weick JP. Perspectives for computational modeling of cell replacement for neurological disorders. Front Comput Neurosci. 2013;7:150.
Bashur CA, Rao RR, Ramamurthi A. Perspectives on Stem Cell-Based Elastic Matrix Regenerative Therapies for Abdominal Aortic Aneurysms. Stem Cells Transl Med. 2013.
Plock JA, Schnider JT, Solari MG, Zheng XXiao, Gorantla VS. Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation. Front Immunol. 2013;4:175.
Birket MJ, Casini S, Kosmidis G, Elliott DA, Gerencser AA, Baartscheer A, Schumacher C, Mastroberardino PG, Elefanty AG, Stanley EG, et al. PGC-1α and Reactive Oxygen Species Regulate Human Embryonic Stem Cell-Derived Cardiomyocyte Function. Stem Cell Reports. 2013;1(6):560-74.
Pasquier J, Rioult D, Abu-Kaoud N, Marie S, Rafii A, Guerrouahen BS, Le Foll F. P-Glycoprotein-Activity Measurements in Multidrug Resistant Cell Lines: Single-Cell versus Single-Well Population Fluorescence Methods. Biomed Res Int. 2013;2013:676845.
Speth JM, Hoggatt J, Singh P, Pelus LM. Pharmacologic increase in HIF1α enhances hematopoietic stem and progenitor homing and engraftment. Blood. 2013.
Liu G-S, Peshavariya HM, Higuchi M, Chan EC, Dusting GJ, Jiang F. Pharmacological priming of adipose-derived stem cells for paracrine VEGF production with deferoxamine. J Tissue Eng Regen Med. 2013.
Stessuk T, Ruiz MArtur, Greco OTadeu, Bilaqui A, Ribeiro-Paes MJosé de O, Ribeiro-Paes JTadeu. Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years. Rev Bras Hematol Hemoter. 2013;35(5):352-357.
Brown JR, Messmer BT, Werner L, Davids MS, Mikler E, Supko JG, Fisher DC, Lacasce AS, Armand P, Jacobsen E, et al. A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia / small lymphocytic lymphoma. Haematologica. 2013.
Yang S-S, Kim N-R, Park K-B, Do Y-S, Roh K, Kang K-S, Kim D-I. A Phase I Study of Human Cord Blood-Derived Mesenchymal Stem Cell Therapy in Patients with Peripheral Arterial Occlusive Disease. Int J Stem Cells. 2013;6(1):37-44.
Shukla N, Kobos R, Renaud T, Steinherz LJ, Steinherz PG. Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia. Pediatr Blood Cancer. 2013.
Ryu Y-J, Cho T-J, Lee D-S, Choi J-Y, Cho J. Phenotypic characterization and in vivo localization of human adipose-derived mesenchymal stem cells. Mol Cells. 2013.
Li W, Reeb AN, Sewell WA, Elhomsy G, Lin R-Y. Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells. PLoS One. 2013;8(5):e65095.

Pages